|1.||Amaral, Leonard: 20 articles (03/2014 - 11/2004)|
|2.||Molnar, Joseph: 11 articles (03/2014 - 11/2004)|
|3.||Kristiansen, Jette E: 7 articles (03/2015 - 01/2005)|
|4.||Viveiros, Miguel: 7 articles (05/2012 - 11/2004)|
|5.||Karakousis, Petros C: 5 articles (12/2014 - 05/2011)|
|6.||van Soolingen, Dick: 5 articles (12/2014 - 01/2010)|
|7.||Dutta, Noton K: 5 articles (12/2014 - 05/2011)|
|8.||Hendricks, Oliver: 4 articles (03/2015 - 01/2005)|
|9.||Kolmos, Hans Jørn: 4 articles (01/2015 - 01/2005)|
|10.||Rho, Seung Bae: 4 articles (07/2014 - 01/2011)|
12/01/2014 - "Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy."
12/01/2013 - "tuberculosis replication rates decreased, those of thioridazine improved. "
09/01/2014 - "In this study, we sought to investigate the sterilizing activity of human-equivalent doses of thioridazine when given in combination with the "Denver regimen" against acute murine tuberculosis. "
01/15/2015 - "The antipsychotic drug thioridazine has potential for treatment of multidrug-resistant microbes including tuberculosis but also causes cardiotoxic QT interval prolongation. "
12/01/2014 - "The articles by De Knegt et al. and Singh et al. in a recent issue of this Journal address one of the current debates regarding the potential role of thioridazine in the treatment of tuberculosis. "
|2.||Schizophrenia (Dementia Praecox)
06/24/1972 - "A comparative study of the efficacy of bilateral and unilateral electroconvulsive therapy with thioridazine in acute schizophrenia."
11/01/2003 - "Thioridazine, which the UK Committee on the Safety of Medicines (CSM) recently recommended should be used only for second-line treatment of schizophrenia in adults, was the most commonly prescribed antipsychotic throughout the study period. "
08/01/1984 - "The relationship of plasma and red blood cell (RBC) levels of thioridazine to clinical response in schizophrenia was evaluated in a fixed-dose study. "
07/01/1963 - "[Clinical trials with thioridazine in schizophrenia]."
04/01/1960 - "Clinical trials with melleril (TP21) in the treatment of schizophrenia. "
|3.||Extensively Drug-Resistant Tuberculosis
06/01/2010 - "Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!"
03/01/2012 - "Potential therapy of multidrug-resistant and extremely drug-resistant tuberculosis with thioridazine."
01/01/2012 - "Why and How the Old Neuroleptic Thioridazine Cures the XDR-TB Patient."
06/01/2010 - "Although thioridazine is beyond patent protection, its use for the therapy of XDR TB is new and therefore, a patent may be sought for "use as an anti-XDR TB agent"."
06/01/2010 - "Therapy Of XDR TB with thioridazine a drug beyond patent protection but eligible for patent "as new use"."
06/01/2010 - "We have been able to demonstrate that thioridazine, a neuroleptic in safe use for over forty years, enhances the killing of phagocytosed Mycobacterium tuberculosis regardless of its antibiotic susceptibility profile and cure the mouse of a Mycobacterium tuberculosis pulmonary infection. "
02/01/2010 - "Thioridazine protects the mouse from a virulent infection by Salmonella enterica serovar Typhimurium 74."
07/01/2006 - "The authors do not suggest that thioridazine be used indiscriminately for MDRTB or intracellular infections produced by MRSA. "
10/01/1999 - "Thioridazine treatment modifies the evolution of Trypanosoma cruzi infection in mice."
01/01/2010 - "Thioridazine treatment resulted in a significant reduction of colony-forming-units of the susceptible (-4.4 log CFU, p<0.05) and multidrug-resistant tuberculosis bacilli (-2.4 log CFU, p<0.009) in the lung both at one and two months after infection, compared to controls. "
|5.||Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
03/01/2012 - "Thioridazine: an old neuroleptic effective against totally drug resistant tuberculosis."
05/01/2011 - "The advantages are that thioridazine is inexpensive, effective against drug resistant tuberculosis, well characterized and unlikely to induce drug resistance. "
01/15/2015 - "If these results are valid in humans, (-)-thioridazine may be a safer drug for treatment of multidrug-resistant tuberculosis and other microbes. "
06/01/2013 - "Recent clinical reports suggest that thioridazine may play a role in the treatment of drug-resistant tuberculosis. "
12/01/2012 - "The added effect of thioridazine in the treatment of drug-resistant tuberculosis."
|7.||Anti-Bacterial Agents (Antibiotics)
|1.||Home Nursing (Nursing, Home)